Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 491 - 500 of 589 results

First page
Previous page
Next page
Next page

STEARYL/OCTYLDODECYL CITRATE CROSSPOLYMER

PN88NW0KPK

Status:

Possibly Marketed Outside US

Source:

21 CFR 347

(2021)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f75f70c4-7fba-4f01-a485-ad1d34500f8d

First approved in 2013

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96fd2cf8-cb07-4ec1-8946-8e862f6d8377

Class:

CONCEPT

SUNBURST ORANGE TETRA TRANSGENIC WHOLE (YT2012 CONSTRUCTS)

1REX7U5H8Y

Status:

Possibly Marketed Outside US

Source:

Sunburst Orange Tetra by GloFish LLC

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec0a277f-bf24-434f-b708-759e4efd2844

First approved in 2013

Source:

Sunburst Orange Tetra by GloFish LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec0a277f-bf24-434f-b708-759e4efd2844

Class:

CONCEPT

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

DC4ELG1BFZ

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

I282A48KKK

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN

Z48BXE2O2P

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

69H0YJ871T

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

058U2312CR

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

Class:

CONCEPT

INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN

POQ8DQO9S3

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

Class:

CONCEPT

INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

D2053D6YQU

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

Class:

CONCEPT

PEG-12 DIMETHICONE/PPG-20 CROSSPOLYMER

965K72OQXO

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2417124e-d934-40f7-9a87-578dff00ed34

First approved in 2013

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2417124e-d934-40f7-9a87-578dff00ed34

Class:

CONCEPT

Concept

STEARYL/OCTYLDODECYL CITRATE CROSSPOLYMER

Concept

SUNBURST ORANGE TETRA TRANSGENIC WHOLE (YT2012 CONSTRUCTS)

Concept

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

PEG-12 DIMETHICONE/PPG-20 CROSSPOLYMER

Showing 491 - 500 of 589 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1